- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07383974
The Impact of 12 Week Retention of Nutrients on Skin and the Perception of Physical Health Status
This is a randomized, double-blind, placebo-controlled clinical trial exploring the effects of a 12-week dietary supplement regimen on skin condition and perceived overall health status.
The study will involve 120 healthy Chinese adults aged 18 and above with low daily fruit and vegetable intake. Participants will be randomly assigned to one of two groups: one group will take a combination of Nu Skin's Vitamin C & Green Tea Capsules and Multivitamin & Mineral Capsules, while the other group will take a matching placebo.
The primary goal is to assess if the supplement combination improves skin health after 12 weeks, measured through specialized facial imaging (assessing spots, redness, evenness) and probe measurements (assessing elasticity, moisture, gloss). Secondary goals include evaluating changes in participants' self-perceived health status (via quality of life, fatigue, and digestive health questionnaires), psychological resilience, memory, and exploring a new method for measuring skin carotenoid levels.
This study is not intended to verify the approved health functions of the products but to explore the potential combined effects of antioxidant and nutritional supplementation on skin and general well-being.
Study Overview
Status
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yanwen Jiang
- Phone Number: 13501700841
- Email: jiangyanwen@china-norm.com
Study Locations
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China, 200072
- Recruiting
- Shanghai China-norm Quality Technical Service Co., Ltd.
-
Contact:
- Yanwen Jiang
- Phone Number: 13501700841
- Email: jiangyanwen@china-norm.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Chinese adults of Asian descent aged 18 and above;
- Daily fruit and vegetable intake < 240g (calculated based on the fruit and vegetable section of the food frequency questionnaire);
- S3 measurement index < 30000;
- Participants must possess basic Chinese reading comprehension and expression skills, and be able to independently complete questionnaire surveys;
- Voluntary participation in the test and signing of the informed consent form;
- Willingness to comply with all evaluation requirements.
Exclusion Criteria:
- Presence of open facial skin lesions, clearly visible scars, acne marks, etc.;
- Skin lesions, scars, or significant pigmentation on the hand measurement area;
- Symptoms of skin disease on the face or hand measurement areas;
- Having undergone medical aesthetic procedures within the last 6 months;
- Participation in other clinical trials involving product use within the last 3 months;
- Use of health supplements or nutritional supplements (e.g., vitamins, minerals) within the last 1 month;
- Currently planning for pregnancy, pregnant, or lactating;
- Presence of any disease under current treatment;
- Any other health issues or chronic diseases that affect behavioral or cognitive abilities;
- Other iatrogenic reasons identified by experts or professionals that may affect the evaluation results.
The S3 instrument refers to a Raman spectroscopy-based biophotonic scanner. The threshold for the S3 screening value is based on previously published literature, which indicated that participants with a daily fruit and vegetable intake of less than 240g had an average Raman spectroscopy biophotonic scanner score below 25,000. However, considering practical recruitment challenges, the inclusion criterion was set at < 30,000. The S3 device measures the Skin Carotenoid Index, a non-invasive biomarker reflecting skin carotenoid levels.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo Control Group
|
Participants take a matching placebo combination (identical in appearance and taste to the active supplements) orally twice daily
|
|
Experimental: Supplement Combination Group
|
Participants take a combination of active supplements-specifically, Vitamin C & Green Tea Capsules and Multivitamin & Mineral Capsules-orally twice daily.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Facial Image Capture VISIA-7
Time Frame: Imaging sessions are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks)
|
Imaging sessions are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks)
|
|
Skin Elasticity Test Probe Cutometer
Time Frame: Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks)
|
Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks)
|
|
Skin Gloss Measurement Glossmeter
Time Frame: Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
|
Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
|
|
Skin Moisture Content Corneometer
Time Frame: Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks)
|
Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks)
|
|
Skin Hemoglobin Measurement Mexameter MX18 (Courage & Khazaka, Germany)
Time Frame: Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
|
Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
|
|
Skin Moisture Loss Meter Vapometer (Delfin, Finland)
Time Frame: Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
|
Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
|
|
Skin Carotenoid Index
Time Frame: Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
|
Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Skin Condition Survey
Time Frame: The scales and questionnaires are administered at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
|
This survey assesses participants' subjective perception of their skin condition over the past month.
It consists of two parts: 1) The Fitzpatrick Skin Typing Questionnaire determines the participant's skin type (I-VI) based on genetic predisposition, tanning ability, and sun reaction.
2) The Skin Status Self-Assessment uses a 100mm visual analog scale for participants to rate various aspects of their skin, including photo-damage (acute and chronic), brightness, glossiness, smoothness, hydration, pore appearance, evenness, softness, elasticity, overall wrinkles, appearance, plumpness, firmness, and spots.
|
The scales and questionnaires are administered at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
|
|
Physical Health and Life Status Survey
Time Frame: The survey is administered at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
|
This comprehensive survey evaluates participants' perceived physical health and quality of life over the past month.
It incorporates five validated instruments: the SF-36 Health Survey, the Frequency of Physical Discomfort Questionnaire, the Gastrointestinal Discomfort Symptoms Questionnaire , the Population-Based Visual Fatigue Scale, and the TCM Constitution Classification and Determination Self-Assessment Table .
|
The survey is administered at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
|
|
Psychological State and Memory Level
Time Frame: The assessment is conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
|
This component measures participants' subjective psychological state and memory function over the past month.
It uses two main instruments: 1) The Brief Resilience Scale (BRS) assesses the ability to bounce back from stress and adversity (psychological resilience).
2) The Multifactorial Memory Questionnaire (MMQ) is divided into three subscales evaluating memory satisfaction/ability (Contentment), frequency of memory failures (Ability), and the use of compensatory strategies (Strategy).
|
The assessment is conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
|
|
Self-Evaluation Questionnaire
Time Frame: This questionnaire is administered only at follow-up visits: T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
|
This questionnaire is specifically designed for participants to subjectively evaluate the effects of the product intervention.
It assesses perceived improvements in areas such as energy levels, overall health status, immune function, recovery speed from illness, quality of life, and the product's contribution to long-term health using a Likert scale.
|
This questionnaire is administered only at follow-up visits: T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
|
|
Height and Weight Measurement BMI
Time Frame: Measurements are conducted at T0 (baseline, upon enrollment) and T12w (12 weeks).
|
Body Mass Index (BMI) is calculated from height and weight measurements to assess weight status and changes over the intervention period.
|
Measurements are conducted at T0 (baseline, upon enrollment) and T12w (12 weeks).
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- W25002003
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
National and Kapodistrian University of AthensCompletedHealthy Adults | Healthy Volunteers OnlyGreece
Clinical Trials on Vitamin C & Green Tea Capsules + Multivitamin & Mineral Capsules Combination
-
University of BristolCompleted
-
Maastricht University Medical CenterVitaKUnknownCoronary Artery DiseaseNetherlands
-
University of ManchesterUniversity of Leeds; University of BradfordCompleted
-
Helwan UniversityActive, not recruitingPost Operative Atrial FibrillationEgypt
-
Yeditepe University HospitalUnknownType 2 DiabetesTurkey
-
National Institute on Aging (NIA)Alzheimer's Disease Cooperative Study (ADCS)Completed
-
Supplement Formulators, Inc.CompletedBody Weight ChangesUnited States
-
University College DublinUniversity of Dublin, Trinity College; St. James's Hospital, Ireland; The Adelaide... and other collaboratorsCompletedObesity | OverweightIreland
-
Mid-Atlantic Retina Consultations, Inc.West Virginia UniversityUnknownDiabetic Macular Edema | Neovascular Age-related Macular DegenerationUnited States
-
Rune Skovgaard RasmussenHerlev HospitalNot yet recruitingAlzheimer Disease (AD)